Literature DB >> 15369674

Identification of a human heme exporter that is essential for erythropoiesis.

John G Quigley1, Zhantao Yang, Mark T Worthington, John D Phillips, Kathleen M Sabo, Daniel E Sabath, Carl L Berg, Shigeru Sassa, Brent L Wood, Janis L Abkowitz.   

Abstract

FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-erythroid, CFU-E) and severe anemia in cats. In this report, we demonstrate that human FLVCR exports cytoplasmic heme and hypothesize that human FLVCR is required on developing erythroid cells to protect them from heme toxicity. Inhibition of FLVCR in K562 cells decreases heme export, impairs their erythroid maturation and leads to apoptosis. FLVCR is upregulated on CFU-E, indicating that heme export is important in primary cells at this stage. Studies of FLVCR expression in cell lines suggest this exporter also impacts heme trafficking in intestine and liver. To our knowledge, this is the first description of a mammalian heme transporter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369674     DOI: 10.1016/j.cell.2004.08.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  174 in total

Review 1.  Heme metabolism and erythropoiesis.

Authors:  Jacky Chung; Caiyong Chen; Barry H Paw
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

2.  Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.

Authors:  Zhantao Yang; John D Philips; Raymond T Doty; Pablo Giraudi; J Donald Ostrow; Claudio Tiribelli; Ann Smith; Janis L Abkowitz
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

3.  Heme utilization in the Caenorhabditis elegans hypodermal cells is facilitated by heme-responsive gene-2.

Authors:  Caiyong Chen; Tamika K Samuel; Michael Krause; Harry A Dailey; Iqbal Hamza
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

4.  Transepithelial heme-iron transport: effect of heme oxygenase overexpression.

Authors:  M J Mendiburo; S Le Blanc; A Espinoza; F Pizarro; M Arredondo
Journal:  Eur J Nutr       Date:  2010-11-16       Impact factor: 5.614

5.  Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa.

Authors:  Anjali M Rajadhyaksha; Olivier Elemento; Erik G Puffenberger; Kathryn C Schierberl; Jenny Z Xiang; Maria L Putorti; José Berciano; Chantal Poulin; Bernard Brais; Michel Michaelides; Richard G Weleber; Joseph J Higgins
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

6.  Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.

Authors:  John Phillips; Collin Farrell; Yongming Wang; Ashwani K Singal; Karl Anderson; Manisha Balwani; Montgomery Bissell; Herbert Bonkovsky; Toni Seay; Barry Paw; Robert Desnick; Joseph Bloomer
Journal:  Mol Genet Metab       Date:  2018-10-22       Impact factor: 4.797

7.  The major facilitator transporter Str3 is required for low-affinity heme acquisition in Schizosaccharomyces pombe.

Authors:  Vincent Normant; Thierry Mourer; Simon Labbé
Journal:  J Biol Chem       Date:  2018-03-16       Impact factor: 5.157

8.  Regulation of intracellular heme trafficking revealed by subcellular reporters.

Authors:  Xiaojing Yuan; Nicole Rietzschel; Hanna Kwon; Ana Beatriz Walter Nuno; David A Hanna; John D Phillips; Emma L Raven; Amit R Reddi; Iqbal Hamza
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

Review 9.  Library screening and receptor-directed targeting of gammaretroviral vectors.

Authors:  Peter M Mazari; Monica J Roth
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

Review 10.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.